Legislation in Chinese autonomous region would eliminate anonymous HIV testing, require names

NewsGuard 100/100 Score

"Health officials in southern China are proposing new legislation to require real-name registration for HIV testing, a move aimed at lowering infection rates that has sparked controversy over personal privacy," the Wall Street Journal's "China Real Time Report" blog reports. It notes that China's Xinhua News Agency recently reported that the legislation, proposed in China's Guangxi Zhuang autonomous region, also would mandate people testing positive for HIV must inform their spouses and partners.

However, "[p]rivacy advocates argue that draft legislation would likely drive away a high-risk population who would otherwise test if their privacy were protected," the blog writes, noting, "Discrimination against China's estimated 740,000 HIV-positive is highly prevalent in the country." The blog adds, "Senior health officials in Beijing are backing the legislation, saying that identity disclosure will boost the speed of test results and early treatment, Xinhua said, citing Wang Yu, director of the Chinese Center for Disease Control and Prevention" (Burkitt, 2/14).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common HIV drugs linked to reduced Alzheimer's disease risk